JPH06298779A - ヘテロ環イミノビスメチレンビスホスホン酸誘導体 - Google Patents

ヘテロ環イミノビスメチレンビスホスホン酸誘導体

Info

Publication number
JPH06298779A
JPH06298779A JP5087692A JP8769293A JPH06298779A JP H06298779 A JPH06298779 A JP H06298779A JP 5087692 A JP5087692 A JP 5087692A JP 8769293 A JP8769293 A JP 8769293A JP H06298779 A JPH06298779 A JP H06298779A
Authority
JP
Japan
Prior art keywords
acid derivative
iminobismethylenebisphosphonic
group
formula
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5087692A
Other languages
English (en)
Japanese (ja)
Inventor
Takehiro Yoshikawa
雄裕 吉川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Priority to JP5087692A priority Critical patent/JPH06298779A/ja
Priority to EP94105550A priority patent/EP0620227A1/en
Priority to AU59432/94A priority patent/AU673895B2/en
Priority to FI941712A priority patent/FI941712A7/fi
Priority to US08/227,351 priority patent/US5441945A/en
Priority to CA002121313A priority patent/CA2121313A1/en
Priority to NO941336A priority patent/NO303120B1/no
Priority to HU9401070A priority patent/HU217443B/hu
Priority to TW083103655A priority patent/TW279164B/zh
Publication of JPH06298779A publication Critical patent/JPH06298779A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP5087692A 1993-04-15 1993-04-15 ヘテロ環イミノビスメチレンビスホスホン酸誘導体 Pending JPH06298779A (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP5087692A JPH06298779A (ja) 1993-04-15 1993-04-15 ヘテロ環イミノビスメチレンビスホスホン酸誘導体
EP94105550A EP0620227A1 (en) 1993-04-15 1994-04-11 Heterocyclic iminobismethylenebisphosphonic acid derivatives
AU59432/94A AU673895B2 (en) 1993-04-15 1994-04-13 Heterocyclic iminobismethylenebisphosphonic acid derivatives
FI941712A FI941712A7 (fi) 1993-04-15 1994-04-13 Heterosykliset iminobismetyleenibisfosfonihappojohdannaiset
US08/227,351 US5441945A (en) 1993-04-15 1994-04-13 Heterocyclic iminobismethylenebisphosphonic acid derivatives
CA002121313A CA2121313A1 (en) 1993-04-15 1994-04-14 Heterocyclic iminobismethylenebisphosphonic acid derivatives
NO941336A NO303120B1 (no) 1993-04-15 1994-04-14 Heterocykliske iminobismetylen-bisfosfonsyrederivater, farmas÷ytiske midler inneholdende dem samt deres anvendelse
HU9401070A HU217443B (hu) 1993-04-15 1994-04-14 Heterociklusos imino-bisz-metilén-biszfoszfonsav-származékok, eljárás előállításukra, és ezeket hatóanyagként tartalmazó gyógyszerkészítmények
TW083103655A TW279164B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-04-15 1994-04-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5087692A JPH06298779A (ja) 1993-04-15 1993-04-15 ヘテロ環イミノビスメチレンビスホスホン酸誘導体

Publications (1)

Publication Number Publication Date
JPH06298779A true JPH06298779A (ja) 1994-10-25

Family

ID=13921987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5087692A Pending JPH06298779A (ja) 1993-04-15 1993-04-15 ヘテロ環イミノビスメチレンビスホスホン酸誘導体

Country Status (9)

Country Link
US (1) US5441945A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0620227A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH06298779A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU673895B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2121313A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI941712A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU217443B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO303120B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW279164B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014522808A (ja) * 2011-06-17 2014-09-08 サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィク 二官能性ホスホネートキレート剤

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435496A1 (de) * 1994-10-04 1996-04-11 Hoechst Ag Imidobisphosphorsäuren, Verfahren zu ihrer Herstellung und Verwendung derselben
ZA975198B (en) 1996-06-13 1997-12-15 Smithkline Beecham Corp Improved process for preparing potassium clavulanate.
WO1998039342A1 (en) 1997-03-07 1998-09-11 Metabasis Therapeutics, Inc. Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
EP1402895A1 (en) * 1997-03-07 2004-03-31 Metabasis Therapeutics, Inc. Benzimidazole inhibitors of fructose 1,6-biphosphatase
AU6452098A (en) 1997-03-07 1998-09-22 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
ATE253073T1 (de) * 1997-03-07 2003-11-15 Metabasis Therapeutics Inc Neue benzimidazol inhibitoren der fructose-1,6- bisphosphatase
SK286080B6 (sk) 1998-09-09 2008-03-05 Metabasis Therapeutics, Inc. Heterocyklické aromatické zlúčeniny obsahujúce fosfonátovú skupinu, ich použitie a farmaceutická kompozícia obsahujúca uvedené zlúčeniny
FR2793796A1 (fr) * 1999-04-14 2000-11-24 Hoechst Marion Roussel Inc Nouveaux derives d'imidazoles, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
CN100358906C (zh) * 2005-09-28 2008-01-02 南京大学 N-(2-苯并咪唑基甲基)亚氨基双甲基膦酸的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674804A (en) * 1968-10-17 1972-07-04 Petrolite Corp Imidazoline phosphonic acids
DE2224516A1 (de) * 1972-05-19 1973-12-06 Henkel & Cie Gmbh Zahnsteinbildung verhindernde mundund zahnpflegemittel
JPS5952805A (ja) * 1982-09-20 1984-03-27 Konishiroku Photo Ind Co Ltd 処理済み強磁性粉末
DE3428524A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
US5057505A (en) * 1986-11-21 1991-10-15 Ciba-Geigy Corporation Substituted aminomethanediphosphonic acids and use in medicaments
EP0317505A1 (de) * 1987-11-13 1989-05-24 Ciba-Geigy Ag Neue Azacycloalkylalkandiphosphonsäuren
US5190930A (en) * 1987-12-11 1993-03-02 Ciba-Geigy Corporation Araliphatylaminoalkanediphosphonic acids
DE3822650A1 (de) * 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4990503A (en) * 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives
US4917737A (en) * 1989-03-13 1990-04-17 Betz Laboratories, Inc. Sealing composition and method for iron and zinc phosphating process
EP0491374B1 (en) * 1990-12-19 1996-01-31 Takeda Chemical Industries, Ltd. Bisphosphonic acid derivatives, their production and use
TW222637B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1991-12-12 1994-04-21 Hoechst Ag

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014522808A (ja) * 2011-06-17 2014-09-08 サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィク 二官能性ホスホネートキレート剤

Also Published As

Publication number Publication date
FI941712L (fi) 1994-10-16
NO941336L (no) 1994-10-17
FI941712A7 (fi) 1994-10-16
HUT68774A (en) 1995-07-28
FI941712A0 (fi) 1994-04-13
HU9401070D0 (en) 1994-07-28
TW279164B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-06-21
HU217443B (hu) 2000-01-28
EP0620227A1 (en) 1994-10-19
NO303120B1 (no) 1998-06-02
US5441945A (en) 1995-08-15
NO941336D0 (no) 1994-04-14
AU673895B2 (en) 1996-11-28
CA2121313A1 (en) 1994-10-16
AU5943294A (en) 1994-10-20

Similar Documents

Publication Publication Date Title
RU2235725C2 (ru) Производные имидазопиридина, способ их получения и промежуточные соединения, фармацевтический препарат на их основе (варианты), способ ингибирования секреции желудочной кислоты и способ лечения состояний, в которые вовлечено инфицирование h.pylori
JP7473642B2 (ja) Btk阻害剤としてのピロロピリミジン系化合物およびその使用
JPH06298779A (ja) ヘテロ環イミノビスメチレンビスホスホン酸誘導体
KR0156239B1 (ko) 헤테로 사이클릭 비스포스폰산 유도체 및 이의 제조방법
JP3224817B2 (ja) 新規なメチレンビスホスホン酸誘導体
HU209305B (en) Process for producing 1h-imidazo(4,5-b)quinolinyl oxyalkanecarboxylic acid amides having increased water solubility, as well as pharmaceutical compositions comprising same
BG64774B1 (bg) Бисулфатна сол на протеазен инхибитор на hiv
HU176807B (en) Process for preparing guanidino-thiazole and imidazole derivatives
US5137880A (en) Bicyclic diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
US5071840A (en) Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
JP3046037B2 (ja) 特に医学画像形成に用いられる化合物および錯体
US4166859A (en) 2-Bromo-6-fluoro-N-(2-imidazolidinylidene)-benzamine and salts thereof and the use to treat hypertension
PL153184B1 (en) Method for manufacturing new heterocyclic derivatives of propane
IE51548B1 (en) N-((4-(3-substituted pyridyl)piperazino)alkyl)azaspirodecanediones
EP0994884A1 (en) Diphosphonic acid salts for the treatment of osteoporosis
PL141443B1 (en) Process for preparing novel derivatives of neutral salts of aminopyridinium hydroxide
DE4320432A1 (de) Substituierte Mono- und Bipyridylmethylderivate
HUP9904077A2 (hu) Kristályos gyógyszerészeti termék
JP2023529047A (ja) 組織損傷の治療に使用するための作用剤
JPH10158267A (ja) 新規プリン誘導体およびこれを含む医薬組成物
JPH0613515B2 (ja) ピラゾロ〔1,5−a〕ピリジン誘導体及びそれを含有する治療剤
JPS61204186A (ja) ピリダジノピロロイソキノリン誘導体
JPH0530828B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
Young et al. Zwitterionic analogs of cimetidine as H2 receptor antagonists
JPH0248587A (ja) 複素環置換ビスフォスフォン酸誘導体及びその医薬

Legal Events

Date Code Title Description
FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080801

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090801

Year of fee payment: 12

LAPS Cancellation because of no payment of annual fees